Here are five points:
1. In 2015, the hip and knee orthopedic surgical robot devices market reached $84 million.
2. The market will grow due to an increasing geriatric population.
3. Hospitals are purchasing robotic surgical devices to enhance clinical outcomes.
4. Robot-assisted surgery is intended to improve accuracy and offer surgeons better control over surgical instruments.
5. Stryker’s Mako total knee application in combination with its Triathlon total knee system will likely increase the company’s market share.
More articles on devices:
Amedica lowers total debt obligations 47% to $12.9M: 5 key notes
Osiris Therapeutics finds better outcomes with Grafix vs. EpiFix — 5 points
CONMED stock “buy” rating reiterated: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
